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1. Introduction
With recent increase in percutaneous cardiac intervention (PCI) the patients undergoing
coronary artery bypass (CABG) are getting more complex with other medical problem. [1] In
some patients standard surgical or percutaneous intervention is no longer available due to its
complexity.
We define complex coronary artery disease (CAD) as condition not amenable to percutaneous
coronary intervention and standard surgical intervention. Conditions for complex CAD
include necessity of reoperative CABG, coronary endarterectomy, calcified aorta and trans‐
myocardial laser revascularization (TMR).
We will discuss each topic with preoperative workup including history and physical, tests and
images. Operative steps will be discussed as well as outcomes and evidence that support the
treatment.
Complex CAD is a challenge for the cardiac surgeons and advanced technique and strategies
are required to treat this difficult condition surgically. Reoperative CABG can be performed
with proper preoperative assessment and surgical planning. Diffusely calcified CAD can be
treated with coronary endarterectomy or TMR. In case of porcelain aorta, circulatory arrest,
off-pump bypass or bilateral internal thoracic artery graft may be used.
A combination of these modalities is likely necessary for cardiac surgeons in the future to treat
patients with complex CAD.
2. Reoperative CABG
Data suggests that fewer patients are undergoing reoperative CABG. [2] From 1990 through
1994, 7.2% of CABG was reoperations which decreased to 2.2% from 2005 through 2009. On
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the other hand, PCI before redo CABG increased from 14.5% (1990 through 1994) to 26.6%
(2005 through 2009). The likely explanation for this is increased use of PCI for patients with
previous CABG and more effective risk factor control. Also, use of internal thoracic artery
(ITA) grafts to left anterior descending (LAD) coronary artery graft decreases the risk of
reoperation and this had become standard graft choice for CABG. The patients who underwent
reoperative CABG had more diabetes, dyslipidemia, hypertension, peripheral vascular disease
and left main disease. In another words, we are seeing less reoperative CABG in a higher risk
patients. Because ITA grafts rarely develop atherosclerosis, reoperation is primarily based on
the patency of the saphenous venous grafts or other arterial grafts. Atherosclerosis occurs in
majority of vein grafts explanted more than 10 years after surgery and this account for almost
all the late graft stenosis. The friability of vein graft atherosclerosis is a substantial risk of distal
coronary artery embolization during PCI and reoperation CABG.
Current recommendations for reoperation CABG include late stenotic vein grafts perfusing
large area of myocardium mainly LAD or new distal CAD which is not perfused by the
previous grafts. [3, 4, 5] Avoidance of graft injury during reentry is the key since perioperative
myocardial infarction is the most significant predictor of mortality in patients undergoing
reoperation. [6, 7]
2.1. Work up
Previous History Detailed specifics of the previous surgery must be obtained. Date of the
surgery, operating surgeon, technical aspects of surgery including number of the grafts
performed, which target was bypassed, presence of ITA grafts and what kind of grafts were
harvested. Also presence of any complication during the last surgery can be obtained from
medical record or directly from the patient. Information regarding aspirin, clopidogrel,
warfarin and dabigatran is important that may dispose to intraoperative and postoperative
bleeding.
Physical Examination Physical examination should include assessment of grafts such as
Allen’s test for radial arterial graft and previous scars to show saphenous vein harvest.
Presence of peripheral artery disease should be assessed in case axillary or femoral cannulation
is used for establishment of cardiopulmonary bypass. Venous Doppler study can be used for
presence of greater and lesser saphenous vein and arterial Doppler studies can be used to
assess the patency of radial and inferior epigastric arteries.
Cardiac Catheterization Cardiac Catheterization is the golden standard test to identify the
new CAD. This will show native vessel anatomy, location of the lesion, patency of the previous
graft including the LITA and size of the conduit. Non patency generally suggests presence of
graft occlusion¸ but one must realize there is a chance that this may be incomplete study.
CT Angiography Another test that is being used in evaluation of the conduit is Computed
tomography (CT) angiography. [8, 9] They are useful because they are able to precisely define
the course of the previously placed conduits especially the LITA grafts. The condition of the
Aorta, stenosis in the subclavian artery can also be assessed. Information gained from these
methods will help guide the surgeons where the previous conduit will be during sternal entry.
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Other images Chest X-ray will provide the information regarding the sternal wires and aortic
calcification and lateral view will provide proximity of the heart to the sternum. If the patient
does not have a sternal wire after previous CABG, it may indicate patient had sternal wound
dehiscence with flap closure. Echocardiogram will provide any wall motion abnormality as
well as any valve abnormality which may change operative strategy. Nuclear stress tests such
as thallium scanning and positron emission tomography and/or stress (exercise or dobuta‐
mine) echocardiogram can be used to assess the viability of the myocardium. If there is no
viability, surgical revascularization may not be indicated.
2.2. Operation
The reoperation CABG is more complex surgery compared to primary CABG. Technical
challenges include sternal reentry, identification of old grafts, presence of graft stenosis and
lack of bypass conduits.
Cardiopulmonary bypass strategy Typically, due to risk of graft injury, axillary or femoral
artery cannulation is performed prior to sternotomy. Venous cannulation is obtained using
femoral vein cannulation. For high risk cases, such as LITA lying underneath the sternum,
Aorta underneath the sternum or right ventricle severly adhered to the sternum, CPB may be
established prior to sternotomy. This allows lung deflation which retracts the heart away from
the sternum.
Operating Room Setup External defibrillators must be attached to the patient prior to incision
in case patient develops nonsustained ventricular arrhythmia during entry and dissection. For
specific cases, thoracotomy can be performed for left sided graft to enable safe and efficient
approach to the targets. [10]
Sternal Reentry Sternal wires are cut and midline of the sternum is marked for sternal reentry.
Oscillating saw is used to divide the anterior table of the sternum. The sternal wires are left in
place to protect the saw from cutting through the posterior table and possibly injuring the
heart. When the anterior table has been divided, ventilation is stopped. And assistant elevate
each side of sternum and posterior table is then sharply divided. Sternal wires are removed as
posterior table is divided.
Dissection Once the sternum is divided, dissection of the mediastinum is performed. Traction
superiorly not laterally is important, since lateral traction can tear the right ventricle and other
important structures. Typically, dissection is performed from inferior to superior direction to
minimize the chance of injuring critical structures. Identification of the diaphragm and
pericardial edge is a marker for correct plane. Right pericardial edge is dissected from
pericardiophrenic angle to the superior vena cava/right atrium junction and aorta is identified.
Innominate vein is identified and dissected to avoid stretch injury. Anticipation of proximal
anastomosis and graft is the key using the preoperative images and operative report. If there
is an injury to the graft, CPB should be initiated and further dissection can be carried out. CPB
can also be initiated on high risk patients to empty the heart and allow it to fall away from the
sternum. Downside of this technique is the need to dissect while on heparin which results in
more bleeding.
Complex Coronary Artery Disease
http://dx.doi.org/10.5772/55251
175
Cardiopulmonary Bypass Once Aorta and right atrium is dissected, the heart can be arrested.
Effective myocardial protection is essential in previously revascularized heart. Both antegrade
and retrograde coronary perfusion are critical. Antegrade cardioplegia may not be effective
for areas supplied by ITA, and may dislodge emboli from the atherosclerotic debris from the
disease vein grafts. On the other hand, retrograde cardioplegia protects from embolization and
removes debris from the retrograde flow. 11 Epiaortic ultrasound is performed to prior to aortic
crossclamp to identify any aortic plaques. [12] Mild hypothermia is induced after patient is
placed on CPB. When there is patent LITA, it is standard practice to dissect and clamp.
However, if the dissection is difficult, moderate hypothermia with either fibrillatory arrest or
systemic hyperkalemia can be used to arrest the heart. Manipulation of the graft should be
avoided until the heart is arrested since this can dislodge the debris.
Revascularization If LITA or RITA was not used, this will be the first choice for conduit. When
ITA is used to replace a vein graft, the old vein graft should be left in place and arterial vessel
should be anastomosed to the same coronary vessel. [13] If the vein graft is ligated this may
induce ischemia to the target vessel. If saphenous vein is used for conduit, distal anastomosis
can be performed directedly to the native coronary artery or to the cuff of 0.5mm of old vein
graft if no distal stenosis is present. Proximal anastomosis is performed in similar fashion;
however, if there are minimal aorta that can be used for anastomosis, graft can be connected
to the previous proximal graft.
If there is associated procedure such as aortic procedure or valve procedure, distal anastomosis
is performed prior to valve procedure to avoid manipulation of the heart after the prosthesis
is in place. When adding ITA graft to stenotic LAD vein graft, it is advised to leave the stenotic
vein graft to avoid hypoperfusion, although there is a risk of distal embolization from the old
vein and competitive flow to the new graft.
2.3. Outcomes
From Society of Thoracic Surgeon database, surgical coronary revascularization has evolved
over the last decade, with reoperative CABG now uncommonly performed in contemporary
practice. reoperative CABG dropped from 6.0% in 2000 to 3.4% in 2009. [14] Reoperative
mortality is high in reoperative group, operative mortality declined from 6.1% in 2000 to 4.6%
in 2009 despite the fact that patients now more frequently present with left main disease,
myocardial infarction, and heart failure. In centers with large operative experience, reports
have demonstrated consistently lower mortality. There is increasing evidence that the
preemptive strategies discussed here may minimize technical and postoperative complication.
[15] Patients also now present more frequently for urgent or emergent surgery and following
previous PCI. They also now have a higher incidence of other comorbidities such as increased
weight, diabetes, hypertension, hypercholesterolemia, renal failure, and cerebrovascular
disease.
Despite operating in patients with more complex coronary artery disease and greater medical
comorbidities, there have been significant improvements in operative morbidity and mortality
in this challenging population. The primary reason for increased mortality appears to be
related to perioperative myocardial infarction (MI), due to graft injury, graft failure, inade‐
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quate myocardial protection and postoperative graft failure. Other significant predictors of
mortality after reoperative coronary revascularization include age, female gender and
emergency operations. [16] Long-term outcome is successful after a high risk surgery. 10-year
survival is reported to be 55-69% and negative predictors of long term survival is preoperative
left ventricular dysfunction, increasing age and diabetes mellitus. [17]
3. Coronary endarterectomy
Coronary endarterectomy is performed when the target has severe atherosclerosis and is not
a suitable target. This procedure removes the atherosclerotic plaques with the intima and
allows the conduit be anastomosed to the target. Often, decision of coronary endarterectomy
is made intraoperatively and conduit is anastomosed to the endarterectomized vessel. This
requires precise technique and experience since inadequate procedure leads to occlusion of
the native artery and the bypass conduit. Main perioperative challenge is maintainance of
patency because removal of the endothelial surface of the coronary artery disposed to platelet
aggregation and subsequent thrombus formation. Therefore, anticoagulation method includ‐
ing usage of postoperative heparin and clopidogrel is encouraged.
3.1. Operation
Right coronary artery (RCA) is the most common vessel which coronary endarterectomy is
performed. LAD endarterectomy is a technically complex procedure when compared to RCA
endarterectomy due to the location and configuration of the septal and diagonal branches.
LAD atherosclerotic core is narrow and delicate which increases the risk of disruption under
tension. Unidirectional traction on the plaque can cause shearing off the branches. It is quite
common that an extended arteriotomy or multiple arteriotomies are performed to achieve
adequate plaque extraction. In cases where an extended arteriotomy is performed, the
proximal third is used as the site of LITA anastomosis while the distal aspect of the vessel is
reconstructed with a vein patch. In cases where 2 or more distinct arteriotomies are created,
the LITA may be used for both sites as a separate graft; however, it is common practice that
the LITA be used for 1 arteriotomy site and vein graft(s) used for the remainder. [18]
Endarterectomy Endarterectomy for a diffusely diseased coronary artery is used when 1-mm
probe is not passed. It is often necessary to create long arteriotomy. After the coronary
arteriotomy, an endarterectomy spatula was used to identify the plane of dissection and then
to mobilize the plaque proximally and distally. A 1-mm probe was advanced gently through
the plane of dissection to break away resistant adhesions. A combination of gentle traction on
the plaque and countertraction on the adventitia is useful to extract the plaque. When proper
distal tapering of the specimen was not achieved, the arteriotomy was extended distally for
complete extraction of the plaque. The proximal end of the endarterectomy should be distal
to the most proximal lesion, to avoid competitive flow through the native coronary artery, to
the level of the first diagonal branch at most. The atherosclerotic plaque varies from soft to
extremely calcified and adherent. This characteristic dictates the length of the arteriotomy
Complex Coronary Artery Disease
http://dx.doi.org/10.5772/55251
177
inasmuch as adherent plaques cannot be removed easily through a limited arteriotomy to at
least the distal two thirds of the length of the target. If this was the case, the arteriotomy was
extended to allow for complete extraction of the atherosclerotic core.
Cardioplegia Flush After complete extraction, retrograde cardioplegic solution was given to
flush out any debris that may have embolized distally. A visible flow of retrograde cardioplegic
solution through the diagonal and septal branches is indicative of successful endarterectomy.
Vein Patch The saphenous vein patch was applied to the endarterectomized vessel with a long
arteriotomy and the LITA was then applied to either the middle of the vein patch or the
proximal end of the arteriotomy or LITA onlay patch grafting was used for a relatively short
arteriotomy after confirming that there was no tension on the graft.
Myocardial Protection Myocardial protection is achieved with combination of antegrade and
retrograde blood cardioplegia. Retrograde cardioplegia is essential during endarterectomy as
it allows for flushing of debris proximally, thereby minimizing the risk of myocardial infarction
secondary to plaque emboli. Furthermore, retrograde cardioplegia serves a diagnostic
purpose; brisk flow through the entire artery indicates complete plaque extraction.
Postoperative Drug Regimen Prevention of platelet aggregation and thrombus formation is
crucial to prevent graft and native vessel occlusion. An aggressive protocol is generally
required and includes intravenous heparin in the immediate postoperative phase as well as
lifetime treatment with clopidogrel (with loading dose) and aspirin.
3.2. Outcome
The risk of endarterectomy patients are higher compared to CABG alone. In some reports, long
term patency is inferior to CABG, but in experienced hands operative mortality of 3.0% and
5-year survival of 87% can be achieved. [19] The most significant complication is periooperative
MI after endarterectomy. It is significant higher compared to CABG alone including MI
occurrence which occurs in 5-10%. [20] Multiterritory endarterectomy is associated with worse
long term survival (64% 5-year survival and 36% 10-year survival), but this could be due to
higher risk patient population. [21]
LAD endarterectomy was intially reported with increased incidence of morbidity and
mortality. [22 23] With technical modifications including LITA grafting with saphenous vein
patch and LITA onlay patch grafting, the outcomes in this high risk group has significantly
improved. [24] Endarterectomy provides good results and mainstay of the treatments for
patients with severe diffuse coronary artery disease not amenable to PCI and traditional
surgical intervention.
4. Calcified aorta
The atherosclerotic involvement of the ascending aorta presents technical challenge in patients
undergoing CABG. The degree of calcification ranges from isolated plaques to total calcifica‐
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tion which is known as porcelain aorta. The danger of applying cross clamp is associated with
markedly increased incidence of cerebral or systemic embolism. The avoidance of multiple
aortic manipulations is the key and strategy must be designed based on this principle.
Atherosclerotic disease of the ascending aorta is becoming an increasing problem and is
important to understand the prevalence of this disease entity. Mills and Everson reported 2.0%
of unclampable aorta in their CABG population of 1735 patients. [25] Other reports have
indicated its occurrence between 2-5% [26, 27]. Goto et al reported in their 463 patients
undergoing CABG reported stroke rate of 10.5% in patients with severe atherosclerosis
compared with 1.8% in normal or near-normal control patients. [28] The challenges in such
situation are to make the accurate diagnosis and operative strategy.
4.1. Work up
Due to its potential to modify surgical strategy, preoperative or intraoperative diagnosis of
unclampable aorta is the key. Accurate diagnosis of aortic atherosclerotic disease is of para‐
mount importance. No diagnostic criteria have been established to date, and often unclamp‐
able aorta is diagnosed intraoperatively by manual palpation or epiaortic ultrasonography.
Disease of the carotid artery and abdominal aorta, stenosis of LAD and age has been reported
to be associated with unclampable aorta. [29] Given the predictors of atheromatous aortic
disease are age, hypertension, diabetes, dyslipidemia, peripheral vasculopathy and diabetes
[30], screening for calcified aorta is recommended in these patient groups.
Images- CXR, Cath, CT scan, TEE Chest X-ray and cardiac catheterization images may
demonstrate the presence of atherosclerosis but is not always sensitive. Routine use of
screening CT scan in this high risk group is useful to prevent incidence of stroke. [31] CT scan
without contrast will delineate the white calcium in clear contrast to the non-calcified aorta
which will appear dark. Intraoperatively, epiaortic ultrasound is superior to manual palpation
of the ascending aorta and to Transthoracic echocardiography (TEE) for detection of athero‐
sclerosis. [32]
Epiaortic Ultrasound Epiaortic ultrasound may reduce the frequency of neurological injury
after surgery due to cerebral embolism by allowing for the identification and avoid atheroma
at the site of cannulation and further manipulation. Introduction of epiaortic ultrasound was
associated with reduction in prevalence of stroke from 1.2% to 0.7% in retrospective review of
8547 patients undergoing CABG surgery. [33] With this, epiaortic scanning now appears to be
the gold standard in diagnosis of atherosclerosis in ascending aorta.
4.2. Operation
Management of this complex disease remains a major dilemma. Several techniques including
aortic graft replacement, aortic endarterectomy, no touch technique and off-pump bypass has
been described to cope with this difficult problem.
Techniques Using Hypothermic Circulatory Arrest Both Aortic graft replacement and
endarterectomy are performed using period of hypothermic circulatory arrest.
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• Deep Hypothermia Deep hypothermia (18-20°C) should be attained on CPB. Following
fibrillation of the heart, a left ventricular vent is placed.
• Distal Anastomosis During the cooling phase of CPB, the distal anastomoses are performed
in the following order: LAD, RCA/posterior descending artery, and marginal branches. Of
note, when the heart is lifted during construction of distal anastomoses, bypass flow should
be reduced to allow for decompression, thereby optimizing exposure and minimizing
damage to the heart. Frequently, at least 1 proximal anastomosis is performed under a brief
period of circulatory arrest.
• Endarterectomy When calcification is localized, endarterectomy can be performed under
circulatory arrest to created portion of aorta which is decalcified to place a crossclamp.
• Ascending Aorta Replacement In extreme case, the ascending aorta should be replaced
under deep hypothermic circulatory arrest. Proximal anastomosis is performed directly to
the graft.
No touch Technique  No touch technique described by Suma et  al  can be used [34].  In
this instance, CPB is established between right atrium and aortic arch or femoral artery.
Left  ventricular  vent  is  placed.  Aortic  cross  clamping  and  cardioplegia  delivery  was
avoided.  Ventricular  fibrillation  was  induced  while  target  was  occluded  using  elastic
stitches. Pedicled artery graft is used for anastomosis. In case the saphenous vein is used,
it is anastomosed to the artery graft or to the ascending aorta where calcification is spared.
Off-pump bypass Off-pump bypass can be used in case arch and femoral artery is calcified as
well. In this case, all arterial revascularization is performed using in situ internal thoracic and
radial artery. Y grafts are created to internal thoracic artery if radial artery is used.
4.3. Outcome
Aortic  endarterectomy and aortic  graft  replacement  provides  opportunity  to  revascular‐
ize  the  coronary  artery  and  eliminate  danger  of  systemic  emboli.  It  is  reported  to  be
performed safely,  [35,  36]  but  these  procedures  do add complexity  and risk  due to  the
circulatory arrest.
No  touch  technique  and  off  pump  technique  provides  theoretical  benefit  to  the  proce‐
dure,  but  has  not  been  able  to  provide  definite  superiority.  Off  pump technique  offers
inferior  possibility  of  complete  revascularization  especially  to  the  lateral  branches  of
circumflex  artery.  On the  other  hand,  no  touch  technique  still  requires  insertion  of  the
arterial  cannula  which  can  predispose  to  systemic  and  cerebral  emboli.  Gaudino  et  al
compared  these  two techniques  in  211  unclampable  aorta  cases  and  reported  no  touch
technique  had  greater  incidence  of  neurological  complications,  renal  insufficiency,  and
stay in the intensive care unit and hospital. However, at midterm follow-up, more patients
of  the  off  pump  group  had  ischemia  recurrence.  [37]  Stroke  rate  was  2.3%  and  in-
hospital mortality was 2.8% in this study.
Artery Bypass180
5. Transmyocardial laser revascularization
Transmyocardial  laser  revascularization  (TMR)  is  one  of  the  first  described  surgical
procedures  intended  to  treat  severe  diffuse  CAD  not  amenable  to  CABG  or  PTCA  in
patients  who  have  had  previous  percutaneous  coronary  interventions  and/or  CABG
procedures.  This severe coronary artery disease can lead to incomplete revascularization
following CABG and is  powerful  independent  perioperative  adverse  events.  Indications
for  TMR  include  NYHA  class  III/IV  symptoms  refractory  to  medical  treatment  with
coronary disease  that  is  not  amenable  to  revascularization.  [38,  39,  40]TMR is  generally
contraindicated in patients who are candidates for revascularization or those who are not
candidates but have an ejection fraction below 20%.
By inducing angiogenesis with a laser (carbon dioxide, holminumyttrium– aluminum-
garnett), TMR has been shown to decrease the severity of angina symptoms compared to
medical therapy. [41, 42] As such, the primary indication for TMR is persistent and disabling
angina refractory to medical therapy. Owing to its success as sole therapy, TMR is used in
conjunction with CABG. The safety and efficacy of TMR in this subset of patients has been well
described; operative mortality and morbidity may be significantly less than CABG alone. [43]
Since Food and Drug Administration (FDA) approval in 1998, over 20,000 TMR procedures
have been performed in the United States. [44]
5.1. Operation
Left thoracotomy and Heart Exposure A left anterolateral thoracotomy is the incision of choice
in patients undergoing TMR as the sole surgical procedure. The heart is exposed, allowing for
the access to the anterior, apical, and posterolateral planes of the left ventricle. Careful attention
must be paid to not injure the previous bypass grafts. LAD is identified and used as a landmark
for the location of the septum. TMR is provided through a hand piece that delivers energy
through hollow tubes to the epicardium.
Choose type of laser Type of Laser Only CO2 and Holmium-chromium: YAG lasers (Ho:YAG)
are clinically approved for TMR. The result of any laser-tissue interaction is dependent on both
laser and tissue variables. CO2 laser has wavelength of 10,600nm, whereas Ho:YAG laser has
wavelength of 2,120nm. The laser is synchronized to occur on the R-wave of the electrocar‐
diogram to avoid induction of arrhythmias.
Application of laser Pulse energy of 20-30 J over 4 pulses per second creates 1-mm channels
in the myocardium that can be visualized with a transesophageal echocardiogram. Using the
CO2 laser, channels are first created at the base of the heart and are separated from each other
by 1 cm to the apex of the heart starting inferiorly and working superiorly to the anterior surface
of the heart. As there is some bleeding from the channels, gravity will keep the field clean by
starting inferiorly.
It should be noted that TMR does not provide any added benefit to areas of myocardium that
are scarred and have no viability. TMR on the transmural scar will not only be non-beneficial,
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it will cause bleeding which may be problematic. Detection of transmural penetration is
primarily by tactile and auditory feedback.
5.2. Outcome
Mortality following TMR ranges from 1% to 5%; however, this low rate of mortality is primarily
generalized to patients who are electively taken to the operating room and are hemodynami‐
cally stable. When these patients are taken to the operating room emergently, mortality is
reported to be 10-20%. One-year survival following TMR ranges from 79% to 96% and is not
significantly different from patients who undergo medical therapy. The primary advantage of
TMR over medical therapy and the principal indication for intervention is the reduction in
symptomatology; studies have found that 25%-76% of patients will achieve a decrease of 2 or
more angina classes following intervention, which is not the case of patients undergoing
medical intervention. Review of the randomized controlled study suggests improvement in
perfusion for CO2 TMR treated patients. [45 46] Long term results suggest improved angina
symptoms and decreased hospitalization in five years. [47]
However, the benefit of TMR is controversial. Cochrane review published it data after
reviewing seven studies (1137 participants of which 559 randomized to TMR). Overall, 43.8 %
of patients in the treatment group decreased two angina classes as compared with 14.8 % in
the control group. Mortality at both 30 days (4.0 % in the TMR group and 3.5 % in the control
group) and 1 year (12.2 % in the TMR group and 11.9 % in the control group) was similar in
both groups. The 30-days mortality as treated was 6.8% in TMLR group and 0.8% in the control
group, showing a statistically significant difference. Their conclusion was there is insufficient
evidence to conclude that the clinical benefits of TMLR outweigh the potential risks and the
procedure is associated with a significant early mortality. [48]
TMR is used in conjunction with CABG as well. One randomized controlled study have found
that TMR combined with CABG may confer excellent perioperative and survival rates,
including decreased opeartive mortality, inotropic support, and intensive care unit stay, while
prolonging 1-year survival compared to those patients undergoing CABG alone. [49] Further‐
more, patients who undergo both procedures appear to be less symptomatic at follow-up.
In conclusion application of TMR in selected group for the treatment with severe angina due
to diffuse disease can be used achieves a more complete revascularization.
6. Conclusion
Complex CAD remains a challenge for cardiac surgeons; however, evolving techniques and
strategies can be used to overcome this challenge. Although reoperative CABG is a high-risk
procedure, proper preoperative assessment and surgical planning has yielded excellent
results. Patients who are not candidates for CABG or percutaneous coronary interventions due
to diffusely diseased vessels can be offered coronary endarterectomy. Calcified aorta encoun‐
tered during surgery can be managed by aortic replacement, endarterectomy, using no touch
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technique or off-pump CABG. TMR may be indicated for patients who have exhausted non
surgical options. The outcomes in this complex coronary artery surgery are improving and the
results have validated the safety, effectiveness and health outcomes. However, it is crucial to
make good patient selection as well as intraoperative decision. Cardiac surgeons must
familiarize themselves to these procedures as coronary artery disease patients will be more
complex in the future.
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